PHQ-9 Score of 17: Moderately Severe Depression
A PHQ-9 score of 17 indicates moderately severe depression that requires referral to mental health professionals (psychology and/or psychiatry) for formal diagnosis and treatment. 1
Score Interpretation
The PHQ-9 uses the following severity categories based on total score 1, 2:
- 1-7: None/mild symptomatology
- 8-14: Moderate symptomatology
- 15-19: Moderately severe symptomatology
- 20-27: Severe symptomatology
Your score of 17 falls squarely in the moderately severe range (15-19), indicating:
- The patient has the majority of depressive symptoms
- Symptoms interfere moderately to markedly with functioning
- May or may not include suicidal ideation 1
Immediate Clinical Actions Required
1. Assess for Safety First
Before proceeding with any treatment plan, immediately evaluate if the patient is at risk of harm to self or others. If yes, this requires emergency evaluation by a licensed mental health professional, facilitation of a safe environment, one-to-one observation, and harm-reduction interventions 1.
2. Make Mental Health Referral
At this severity level, referral to psychology and/or psychiatry is mandatory for formal diagnosis and treatment initiation 1. This is not optional—the score indicates significant functional impairment requiring specialized mental health intervention.
3. Identify Risk Factors
Document pertinent history and specific risk factors 1:
- Prior mood disorder (with or without prior treatment)
- Comorbid anxiety disorders or substance use
- Other chronic illnesses (coronary heart disease, COPD)
- Recurrent, advanced, or progressive disease (if cancer patient)
- Social factors: single/widowed/divorced status, unemployment, low financial resources, education less than high school
Treatment Implications
Intervention Options
Based on the most recent ASCO guidelines 1, patients at this severity level require:
Psychological interventions delivered by licensed mental health professionals using treatment manuals that include:
- Cognitive change
- Behavioral activation
- Biobehavioral strategies
- Education and relaxation strategies
- Relapse prevention components
Pharmacologic treatment with physician-prescribed antidepressants, with choice informed by:
- Side-effect profiles
- Drug interactions
- Prior treatment response
- Patient age and preference
Monitor regularly for adherence, side effects, and adverse events 1.
Clinical Context and Validation
The PHQ-9 is a validated 9-item self-report scale assessing symptoms of major depressive disorder as defined by DSM-IV criteria 3. Using structured mental health professional interviews as the criterion standard, a PHQ-9 score ≥10 has 88% sensitivity and 88% specificity for major depression 2.
Important caveat: The PHQ-9 screening score does not equal a clinical diagnosis 1. The score of 17 indicates significant symptom burden requiring professional evaluation, but formal diagnosis must be made by a qualified mental health professional using diagnostic criteria.
Measurement Properties
The PHQ-9 demonstrates strong psychometric properties with two underlying factors: cognitive-affective symptoms and somatic symptoms 4. Both domains contribute to the total score, which has strong internal reliability and is sensitive to detecting change over time with treatment 5.
Common Pitfalls to Avoid
- Do not delay referral: A score of 17 is not "borderline"—it requires immediate mental health referral
- Do not treat medical causes alone: While ruling out medical contributors (unrelieved pain, fatigue, delirium, infections, electrolyte imbalances) is important 1, this score necessitates concurrent mental health treatment
- Do not rely solely on primary care management: This severity level exceeds what should be managed without specialist involvement
- Assess suicidality explicitly: The score range includes patients with and without suicidal ideation—always ask directly about item 9 (thoughts of self-harm) 1